Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models.

Lieber GB, Fernandez X, Mingo GG, Jia Y, Caniga M, Gil MA, Keshwani S, Woodhouse JD, Cicmil M, Moy LY, Kelly N, Jimenez J, Crawley Y, Anthes JC, Klappenbach J, Ma YL, McLeod RL.

Eur J Pharmacol. 2013 Oct 15;718(1-3):290-8. doi: 10.1016/j.ejphar.2013.08.019. Epub 2013 Sep 5.

PMID:
24012780
[PubMed - indexed for MEDLINE]
2.

Spironolactone attenuates bleomycin-induced pulmonary injury partially via modulating mononuclear phagocyte phenotype switching in circulating and alveolar compartments.

Ji WJ, Ma YQ, Zhou X, Zhang YD, Lu RY, Guo ZZ, Sun HY, Hu DC, Yang GH, Li YM, Wei LQ.

PLoS One. 2013 Nov 19;8(11):e81090. doi: 10.1371/journal.pone.0081090. eCollection 2013.

PMID:
24260540
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.

Zhu Y, Liu Y, Zhou W, Xiang R, Jiang L, Huang K, Xiao Y, Guo Z, Gao J.

Respir Res. 2010 Mar 20;11:34. doi: 10.1186/1465-9921-11-34.

PMID:
20302663
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230.

Egger C, Gérard C, Vidotto N, Accart N, Cannet C, Dunbar A, Tigani B, Piaia A, Jarai G, Jarman E, Schmid HA, Beckmann N.

Am J Physiol Lung Cell Mol Physiol. 2014 Jun 15;306(12):L1064-77. doi: 10.1152/ajplung.00027.2014. Epub 2014 Apr 11.

PMID:
24727584
[PubMed - indexed for MEDLINE]
5.

Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice.

Li Y, Azuma A, Takahashi S, Usuki J, Matsuda K, Aoyama A, Kudoh S.

Chest. 2002 Dec;122(6):2137-45.

PMID:
12475858
[PubMed - indexed for MEDLINE]
6.

Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension.

Preston IR, Sagliani KD, Warburton RR, Hill NS, Fanburg BL, Jaffe IZ.

Am J Physiol Lung Cell Mol Physiol. 2013 May 15;304(10):L678-88. doi: 10.1152/ajplung.00300.2012. Epub 2013 Mar 1.

PMID:
23457185
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis.

Baowen Q, Yulin Z, Xin W, Wenjing X, Hao Z, Zhizhi C, Xingmei D, Xia Z, Yuquan W, Lijuan C.

Eur J Pharmacol. 2010 Sep 10;642(1-3):134-9. doi: 10.1016/j.ejphar.2010.05.019. Epub 2010 May 26.

PMID:
20510684
[PubMed - indexed for MEDLINE]
8.

EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.

Li YJ, Azuma A, Usuki J, Abe S, Matsuda K, Sunazuka T, Shimizu T, Hirata Y, Inagaki H, Kawada T, Takahashi S, Kudoh S, Omura S.

Respir Res. 2006 Jan 27;7:16.

PMID:
16438734
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model.

Besnard AG, Struyf S, Guabiraba R, Fauconnier L, Rouxel N, Proost P, Uyttenhove C, Van Snick J, Couillin I, Ryffel B.

J Leukoc Biol. 2013 Dec;94(6):1317-23. doi: 10.1189/jlb.0313140. Epub 2013 Aug 23.

PMID:
23975892
[PubMed - indexed for MEDLINE]
10.

Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage.

Garcia O, Carraro G, Turcatel G, Hall M, Sedrakyan S, Roche T, Buckley S, Driscoll B, Perin L, Warburton D.

PLoS One. 2013 Aug 13;8(8):e71679. doi: 10.1371/journal.pone.0071679. eCollection 2013.

PMID:
23967234
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung.

Underwood DC, Osborn RR, Bochnowicz S, Webb EF, Rieman DJ, Lee JC, Romanic AM, Adams JL, Hay DW, Griswold DE.

Am J Physiol Lung Cell Mol Physiol. 2000 Nov;279(5):L895-902.

PMID:
11053025
[PubMed - indexed for MEDLINE]
Free Article
12.

Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.

Du J, Fan YY, Hitomi H, Kiyomoto H, Kimura S, Kong CZ, Noma T, Kohno M, Nishiyama A, Nakano D.

Am J Physiol Renal Physiol. 2009 Sep;297(3):F802-8. doi: 10.1152/ajprenal.00197.2009. Epub 2009 Jun 17.

PMID:
19535572
[PubMed - indexed for MEDLINE]
Free Article
13.

In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.

Serrano-Mollar A, Closa D, Prats N, Blesa S, Martinez-Losa M, Cortijo J, Estrela JM, Morcillo EJ, Bulbena O.

Br J Pharmacol. 2003 Mar;138(6):1037-48.

PMID:
12684259
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.

Kim JW, Rhee CK, Kim TJ, Kim YH, Lee SH, Yoon HK, Kim SC, Lee SY, Kwon SS, Kim KH, Kim YK.

Clin Exp Pharmacol Physiol. 2010 Nov;37(11):1055-63. doi: 10.1111/j.1440-1681.2010.05431.x.

PMID:
20659133
[PubMed - indexed for MEDLINE]
15.

Myeloid mineralocorticoid receptor during experimental ischemic stroke: effects of model and sex.

Frieler RA, Ray JJ, Meng H, Ramnarayanan SP, Usher MG, Su EJ, Berger S, Pinsky DJ, Lawrence DA, Wang MM, Mortensen RM.

J Am Heart Assoc. 2012 Oct;1(5):e002584. doi: 10.1161/JAHA.112.002584. Epub 2012 Oct 25.

PMID:
23316294
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice.

Udalov S, Dumitrascu R, Pullamsetti SS, Al-tamari HM, Weissmann N, Ghofrani HA, Guenther A, Voswinckel R, Seeger W, Grimminger F, Schermuly RT.

BMC Pulm Med. 2010 May 5;10:26. doi: 10.1186/1471-2466-10-26.

PMID:
20444277
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis.

Damazo AS, Sampaio AL, Nakata CM, Flower RJ, Perretti M, Oliani SM.

BMC Immunol. 2011 Oct 19;12:59. doi: 10.1186/1471-2172-12-59.

PMID:
22011168
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Mineralocorticoid receptor and cardiac arrhythmia.

Gravez B, Tarjus A, Jaisser F.

Clin Exp Pharmacol Physiol. 2013 Dec;40(12):910-5. doi: 10.1111/1440-1681.12156. Review.

PMID:
23888997
[PubMed - indexed for MEDLINE]
19.

Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.

Stas S, Whaley-Connell A, Habibi J, Appesh L, Hayden MR, Karuparthi PR, Qazi M, Morris EM, Cooper SA, Link CD, Stump C, Hay M, Ferrario C, Sowers JR.

Endocrinology. 2007 Aug;148(8):3773-80. Epub 2007 May 10.

PMID:
17494996
[PubMed - indexed for MEDLINE]
20.

Complex regulation of pulmonary inflammation and fibrosis by CCL18.

Pochetuhen K, Luzina IG, Lockatell V, Choi J, Todd NW, Atamas SP.

Am J Pathol. 2007 Aug;171(2):428-37. Epub 2007 Jun 14.

PMID:
17569779
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk